Semaglutide · 2026-08-12
ClinicalTrials.gov record NCT07218354
Recruiting at the retained observation.
Open attributed record →Official registry phase
Phase 3 peptide trials
43 selected ClinicalTrials.gov records carrying the official Phase 3 designation. Phase is reported exactly as supplied by the retained registry version; records without a supplied phase are not inferred into this page.
Registry records
43 selected records.
Connected peptides
19 profiles.
Source boundary
ClinicalTrials.gov phase field.
Attributed registry records
Selected records
Survodutide · 2026-08-11
ClinicalTrials.gov record NCT06077864
Completed at the retained observation.
Open attributed record →Survodutide · 2026-08-10
ClinicalTrials.gov record NCT06632444
Recruiting at the retained observation.
Open attributed record →Survodutide · 2026-08-10
ClinicalTrials.gov record NCT06632457
Recruiting at the retained observation.
Open attributed record →Survodutide · 2026-08-10
ClinicalTrials.gov record NCT07754461
Not yet recruiting at the retained observation.
Open attributed record →Dulaglutide · 2026-08-07
ClinicalTrials.gov record NCT06739122
Recruiting at the retained observation.
Open attributed record →Setmelanotide · 2026-08-06
ClinicalTrials.gov record NCT05093634
Completed at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-08-04
ClinicalTrials.gov record NCT07684235
Recruiting at the retained observation.
Open attributed record →Cagrilintide · 2026-08-04
ClinicalTrials.gov record NCT07745504
Not yet recruiting at the retained observation.
Open attributed record →Cagrilintide · 2026-08-03
ClinicalTrials.gov record NCT07220759
Active, not recruiting at the retained observation.
Open attributed record →Retatrutide · 2026-07-30
ClinicalTrials.gov record NCT05882045
Completed at the retained observation.
Open attributed record →Retatrutide · 2026-07-30
ClinicalTrials.gov record NCT05929079
Completed at the retained observation.
Open attributed record →Octreotide · 2026-07-29
ClinicalTrials.gov record NCT00569127
Active, not recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-07-29
ClinicalTrials.gov record NCT07734792
Not yet recruiting at the retained observation.
Open attributed record →Leuprolide · 2026-07-28
ClinicalTrials.gov record NCT04484818
Active, not recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-07-24
ClinicalTrials.gov record NCT07037433
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-07-21
ClinicalTrials.gov record NCT06975111
Recruiting at the retained observation.
Open attributed record →Mazdutide · 2026-07-21
ClinicalTrials.gov record NCT07718126
Not yet recruiting at the retained observation.
Open attributed record →Setmelanotide · 2026-07-15
ClinicalTrials.gov record NCT06596135
Completed at the retained observation.
Open attributed record →Leuprolide · 2026-07-09
ClinicalTrials.gov record NCT02319837
Active, not recruiting at the retained observation.
Open attributed record →Liraglutide · 2026-07-09
ClinicalTrials.gov record NCT04775082
Active, not recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-07-07
ClinicalTrials.gov record NCT05569772
Recruiting at the retained observation.
Open attributed record →Maridebart cafraglutide · 2026-07-02
ClinicalTrials.gov record NCT07037459
Recruiting at the retained observation.
Open attributed record →Mazdutide · 2026-05-27
ClinicalTrials.gov record NCT07469800
Recruiting at the retained observation.
Open attributed record →Elamipretide · 2026-05-20
ClinicalTrials.gov record NCT06373731
Active, not recruiting at the retained observation.
Open attributed record →Linaclotide · 2026-05-14
ClinicalTrials.gov record NCT05652205
Completed at the retained observation.
Open attributed record →Bremelanotide · 2024-11-13
ClinicalTrials.gov record NCT04943068
Completed at the retained observation.
Open attributed record →Semaglutide · 2024-08-30
ClinicalTrials.gov record NCT03574597
Completed at the retained observation.
Open attributed record →Liraglutide · 2023-07-18
ClinicalTrials.gov record NCT03374956
Completed at the retained observation.
Open attributed record →Abaloparatide · 2023-02-15
ClinicalTrials.gov record NCT04064411
Completed at the retained observation.
Open attributed record →Lanreotide · 2022-10-14
ClinicalTrials.gov record NCT00774930
Completed at the retained observation.
Open attributed record →Tesamorelin · 2022-09-30
ClinicalTrials.gov record NCT00608023
Completed at the retained observation.
Open attributed record →Semaglutide · 2022-01-19
ClinicalTrials.gov record NCT03548987
Completed at the retained observation.
Open attributed record →Semaglutide · 2021-11-11
ClinicalTrials.gov record NCT03611582
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-04-05
ClinicalTrials.gov record NCT00380406
Completed at the retained observation.
Open attributed record →Leuprolide · 2016-12-13
ClinicalTrials.gov record NCT00928434
Completed at the retained observation.
Open attributed record →Liraglutide · 2014-09-12
ClinicalTrials.gov record NCT01270789
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-11-06
ClinicalTrials.gov record NCT00002580
Completed at the retained observation.
Open attributed record →Leuprolide · 2013-08-02
ClinicalTrials.gov record NCT00002582
Completed at the retained observation.
Open attributed record →Leuprolide · 2010-11-09
ClinicalTrials.gov record NCT00002881
Completed at the retained observation.
Open attributed record →Teriparatide · 2007-01-26
ClinicalTrials.gov record NCT00191321
Completed at the retained observation.
Open attributed record →Teriparatide · 2007-01-26
ClinicalTrials.gov record NCT00191893
Completed at the retained observation.
Open attributed record →Teriparatide · 2006-07-20
ClinicalTrials.gov record NCT00046137
Completed at the retained observation.
Open attributed record →